论文信息 - A phase I trial of PRN1008, a novel reversible covalent inhibitor of Bruton's tyrosine kinase, in healthy volunteers - 字舞流文

A phase I trial of PRN1008, a novel reversible covalent inhibitor of Bruton's tyrosine kinase, in healthy volunteers

J. Funk | Patrick F. Smith | S. Gourlay | R. Hill | P. Nunn | J. Krishnarajah | D. Tam | D. Karr | M. Masjedizadeh | Danny Tam